REVA Medical Revenue and Competitors

Location

$101.6M

Total Funding

Estimated Revenue & Valuation

  • REVA Medical's estimated annual revenue is currently $7.5M per year.(i)
  • REVA Medical's estimated revenue per employee is $163,043
  • REVA Medical's total funding is $101.6M.

Employee Data

  • REVA Medical has 46 Employees.(i)
  • REVA Medical grew their employee count by 53% last year.

REVA Medical's People

NameTitleEmail/Phone
1
VP Finance and AdministrationReveal Email/Phone
2
VP Regulatory Affairs QAReveal Email/Phone
3
Director Clinical Field OperationsReveal Email/Phone
4
Director, Preclinical & Clinical AffairsReveal Email/Phone
5
Senior Director Research and Development and Program ManagementReveal Email/Phone
6
Director, Information TechnologyReveal Email/Phone
7
Chief Financial OfficerReveal Email/Phone
8
Director Polymer ScienceReveal Email/Phone
9
QC ManagerReveal Email/Phone
10
Chemical Operations ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.3M817%N/AN/A
#2
$8.5M346%N/AN/A
#3
$4.5M18-10%N/AN/A
#4
$8M32-6%N/AN/A
#5
$5.3M210%N/AN/A
#6
$54.2M2169%N/AN/A
#7
$12M48N/AN/AN/A
#8
$10M405%N/AN/A
#9
$30.1M12022%N/AN/A
#10
$14.1M562%N/AN/A
Add Company

What Is REVA Medical?

REVA Medical, Inc. is a pre-revenue medical device company located in San Diego, California, USA that is working to commercialize its proprietary bioresorbable scaffolds, as an alternative to metal stents, to treat coronary artery disease. Scaffolds provide restoration of blood flow, support the artery through the healing process, then disappear (or “resorb”) from the body over a period of time. This resorption allows the return of natural movement and function of the artery, a result not attainable with permanent metal stents. The Company’s Fantom® scaffold has been designed to offer an ideal balance of thinness and strength, with distinct ease-of-use features including complete scaffold visibility under x-ray, expansion with one continuous inflation, and no procedural time limitations. REVA will require regulatory approval before it can commercialize Fantom or any other product.

keywords:N/A

$101.6M

Total Funding

46

Number of Employees

$7.5M

Revenue (est)

53%

Employee Growth %

N/A

Valuation

N/A

Accelerator

REVA Medical News

2022-04-20 - Bioabsorbable Stent Market Size And Forecast | Boston ...

Ltd., Abbott, REVA Medical Amaranth Medical Meril Life Sciences Pvt. ... Boston Scientific Corporation, Arterius Limited, Elixir Medical...

2022-04-19 - Air Medical Rescue Market Size Global Forecast to 2031 ...

A few top players in the industry are Okavango Air Rescue, Acadian Air Med, China Air Medical Company, Hems999, IAS Medical, REVA Air Ambulance,...

2022-04-17 - Bioabsorbable Stents Market: The Coronary Artery Disease ...

The stent plays a vital role in the medical field of cardiology. ... REVA Medical, Elixir Medical Corporation, Biotronik,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9.3M46-78%N/A
#2
$5.3M46N/AN/A
#3
$9.2M460%N/A
#4
$5.3M4648%N/A
#5
$5.2M465%N/A